Summary of the opinions of the Attorney General, 2007

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Summary of the opinions of the Attorney General, 2008

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Summary of the opinions of the Attorney General, 2006

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Summary of the opinions of the Attorney General, 2005

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Summary of the opinions of the Attorney General, 2004

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Summary of the opinions of the Attorney General, 2003

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Summary of the opinions of the Attorney General, 2002

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Summary of the opinions of the Attorney General, 2000

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Summary of the opinions of the Attorney General, 2001

Compiled biennially as Official opinions of the Attorney General in the Report of the Attorney General. Report year ends December 31. Slip opinions of the Attorney General.

Le mariage des prêtres, ou Récit de ce qui s'est passé à trois séances des assemblées générales du district de Saint-Étienne-du-Mont, où l'on a agité la question du mariage des prêtres , avec la motion principale et Les opinions des honorables membres qui ont appuyé la motion...

Comprend : Les opinions des honorables membres qui ont appuyé la motion

Appropriate maintenance treatment for Crohn's disease: results of a multidisciplinary international expert panel - EPACT II

Introduction: Biological. therapy has dramatically changed management of Crohn's disease (CD). New data have confirmed the benefit and relative long-term safety of anti-TNF alpha inhibition as part of a regular scheduled administration programme. The EPACT appropriateness criteria for maintenance treatment after medically-induced remission (MIR) or surgically-induced remission (SIR) of CD thus required updating. Methods: A multidisciplinary international expert panel (EPACT II, Geneva, Switzerland) discussed and anonymously rated detailed, explicit clinical indications based on evidence in the literature and personal expertise. Median ratings (on a 9-point scale) were stratified into three assessment categories: appropriate (7-9), uncertain (4-6 and/or disagreement) and inappropriate (1-3). Experts ranked appropriate medication according to their own clinical practice, without any consideration of cost. Results: Three hundred and ninety-two specific indications for maintenance treatment of CD were rated (200 for MIR and 192 for SIR). Azathioprine, methotrexate and/or anti-TNF alpha antibodies were considered appropriate in 42 indications, corresponding to 68% of all appropriate interventions (97% of MIR and 39% of SIR). The remaining appropriate interventions consisted of mesalazine and a "wait-and-see" strategy. Factors that influenced the panel's voting were patient characteristics and outcome of previous treatment. Results favour use of anti-TNF alpha agents after failure of any immunosuppressive therapy, while earlier primary use remains controversial. Conclusion: Detailed explicit appropriateness criteria (EPACT) have been updated for maintenance treatment of CD. New expert recommendations for use of the classic immunosuppressors as well as anti-TNF alpha agents are now freely available online (www.epact.ch). The validity of these criteria should now be tested by prospective evaluation. (C) 2009 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Édouard Rod : biographie critique, illustrée d'un portrait-frontispice et d'un autographe, suivie d'opinions et d'une bibliographie / par Firmin Roz

Collection : Les célébrités d'aujourd'hui

Jules Claretie : biographie critique illustrée d'un portrait-frontispice et d'un autographe / par Georges Grappe. suivie d'opinions et d'une bibliographie / [signé A.V.]

Collection : Les célébrités d'aujourd'hui